Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

50.0%

2 terminated/withdrawn out of 4 trials

Success Rate

33.3%

-53.2% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

200%

2 of 1 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 1

1(25.0%)

Phase 3

1(25.0%)

4Total

N/A(2)

Phase 1(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT03052920Not ApplicableCompleted

Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial

Role: collaborator

NCT01526408Phase 3Terminated

Famvir for Treatment of Hearing in Unilateral Meniere's Disease

Role: collaborator

NCT02259192Not ApplicableUnknown

Cochlear Implants for Adults With Single-sided Deafness

Role: collaborator

NCT01850225Phase 1Withdrawn

Feasibility Study of Auditory Brainstem Implant in Young Children

Role: collaborator

All 4 trials loaded